Level B· Emerging clinical evidence with positive signalsClinical TrialPubMedOpen access

Isolation and characterization of equine native MSC populations.

Esteves CL., Sheldrake TA., Mesquita SP., Pesántez JJ., Menghini T., Dawson L.

Clinical Trial on Face & Skin, published in Stem Cell Res Ther (2017) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
Stem Cell Res Ther (2017)
Country
England
Reported sample size
—
Source database
PubMed
PMID
28420427
PMCID
PMC5395828
DOI
10.1186/s13287-017-0525-2
Citations
36

Abstract (original English)

Background In contrast to humans in which mesenchymal stem/stromal cell (MSC) therapies are still largely in the clinical trial phase, MSCs have been used therapeutically in horses for over 15 years, thus constituting a valuable preclinical model for humans. In human tissues, MSCs have been shown to originate from perivascular cells, namely pericytes and adventitial cells, which are identified by the presence of the cell surface markers CD146 and CD34, respectively. In contrast, the origin of MSCs in equine tissues has not been established, preventing the isolation and culture of defined cell populations in that species. Moreover, a comparison between perivascular CD146 + and CD34 + cell populations has not been performed in any species. Methods Immunohistochemistry was used to identify adventitial cells (CD34 + ) and pericytes (CD146 + ) and to determine their localization in relation to MSCs in equine tissues. Isolation of CD34 + (CD34 + /CD146 - /CD144 - /CD45 - ) and CD146 + (CD146 + /CD34 - /CD144 - /CD45 - ) cell fractions from equine adipose tissue was achieved by fluorescence-activated cell sorting. The isolated cell fractions were cultured and analyzed for the expression of MSC markers, using qPCR and flow cytometry, and for the ability to undergo trilineage differentiation. Angiogenic properties were analyzed in vivo using a chorioallantoic membrane (CAM) assay. Resul

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
Adipose TissueAngiopoietin-1AnimalsAntigens, CD34CD146 AntigenCells, CulturedHorsesMesenchymal Stem CellsPericytesPrimary Cell Culture

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research